Top 10 Key Players companies in Nicotinamide mononucleotide by Highest Patent Value in the United States in 2019 – Discovery

Free Trial

The Nicotinamide mononucleotide top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Nicotinamide mononucleotide Key Players in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	Metro International Biotech LLC	United States	Biopharmaceutical,Botanical drug,Herb, ...[+2]	Avg patent value: 3.66 M
2	Metrobiotech LLC	United States		Avg patent value: 3.30 M
3	Massachusetts General Hospital	Massachusetts, United States	Substance abuse,Hospitality industry,Health care, ...[+2]	Avg patent value: 3.09 M
4	The General Hospital Corp.	Massachusetts, United States	Health care,Hospitality industry,Vascular Medicine, ...[+2]	Avg patent value: 3.09 M
5	ChromaDex	California, United States	Wellness Programs,Biomedicine,Biotechnology, ...[+2]	Avg patent value: 126,352
6	Mitobridge, Inc.	Massachusetts, United States	Biology,Pharmacy and Therapeutics,Small molecule, ...[+2]	Avg patent value: 79,000
7	Life BioScience, Inc.	New Mexico, United States		Avg patent value: 52,375
8	STARTUP JumpStart Fertility, Inc.	Massachusetts, United States	Health care,Fertility	Avg patent value: 49,333
9	Bioenergy Life Science, Inc.	Minnesota, United States	Clinical trial,Biotechnology	Avg patent value: 30,000
10	STARTUP Seragon Pharmaceuticals, Inc.	California, United States	Estrogen receptor,Medical equipment,Medicine, ...[+2]	Avg patent value: 4,300